ClinicalTrials.Veeva

Menu

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)

Viatris logo

Viatris

Status and phase

Completed
Phase 4

Conditions

Hypertension
Dyslipidemia

Treatments

Drug: Amlodipine/Atorvastatin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00150384
A3841025

Details and patient eligibility

About

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated
  • Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening

Exclusion criteria

  • Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet
  • Subjects with blood pressure at goal

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

106

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems